Complications of calcium hydroxyapatite injections: how to limit the risks
Clinical case of granulomatous inflammation
CaHA injections are safe and effective for restoring soft tissue volume, but in rare cases granuloma formation is possible. This type of complication requires a multidisciplinary approach: early diagnosis, observation and, if necessary, surgical intervention. More details in the article.
Calcium hydroxyapatite (CaHA) consists of homogeneous microspheres (30%) suspended in carboxymethylcellulose, glycerin and a sterile aqueous gel carrier (70%). Naturally occurring in the human body as an inorganic component of bones and teeth, CaHA filler is highly biocompatible, non-toxic, non-irritating and non-antigenic. CaHA has a high safety profile and minimal inflammatory response, and is FDA-approved. With no known allergenic properties, CaHA does not require a prior skin test and can be stored at room temperature.
CaHA-based injectable filler is used for aesthetic or reconstructive procedures, including deep dermal and subcutaneous soft tissue augmentation. It is used to restore volume in lipoatrophy in the face and hands, as well as to correct moderate and deep facial wrinkles and folds (nasolabial and nasolabial).
Full version of the access article in Ukrainian
Read also
- Complications of fractional photothermolysis: prevention and elimination
- Injection techniques: complications in contouring
- Complications of meso- and botulinum therapy: mistakes and preventive measures
- “Don't Complicate”: a mix of training and pleasant recreation in the circle of colleagues
- Injection techniques: mistakes and their consequences
- Hyaluronidase - an integral element in the office of a cosmetologist